[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Drugs for Respiratory Syncytial Virus (RSV) Market Report 2021

September 2016 | 100 pages | ID: U4CAEB1E609EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Drugs for Respiratory Syncytial Virus (RSV)

Revenue, means the sales value of Drugs for Respiratory Syncytial Virus (RSV)

This report studies sales (consumption) of Drugs for Respiratory Syncytial Virus (RSV) in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Ablynx
  • ADMA Biologics
  • Agilvax
  • AlphaVax
  • AmVac
  • Aridis Pharmaceuticals
  • Artificial Cell Technologies
  • Astellas Pharma
  • AstraZeneca
  • Bavarian Nordic
  • Biota Pharmaceuticals
  • Celltrion
  • Codagenix
  • Crucell
  • CureVac
  • Emergent
  • Roche
  • GenVec
  • Gilead Sciences
  • GlaxoSmithKline
  • Humabs BioMed
  • Novavax
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Ribavirin
  • Bronchodilator
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Drugs for Respiratory Syncytial Virus (RSV) in each application, can be divided into
  • Infants (Under 6 Month Old)
  • Babies & Children
  • Adults
United States Drugs for Respiratory Syncytial Virus (RSV) Market Report 2021

1 DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) OVERVIEW

1.1 Product Overview and Scope of Drugs for Respiratory Syncytial Virus (RSV)
1.2 Classification of Drugs for Respiratory Syncytial Virus (RSV)
  1.2.1 Ribavirin
  1.2.2 Bronchodilator
  1.2.3 Type III
1.3 Applications of Drugs for Respiratory Syncytial Virus (RSV)
  1.3.1 Infants (Under 6 Month Old)
  1.3.2 Babies & Children
  1.3.3 Adults
1.4 USA Market Size (Value and Volume) of Drugs for Respiratory Syncytial Virus (RSV) (2011-2021)
  1.4.1 USA Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)
  1.4.2 USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
  1.4.3 USA Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)

2 USA DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) COMPETITION BY MANUFACTURERS

2.1 USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Drugs for Respiratory Syncytial Virus (RSV) Revenue and Share by Manufactures (2015 and 2016)

3 USA DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) (VOLUME AND VALUE) BY TYPE

3.1 USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Type (2011-2021)
3.2 USA Drugs for Respiratory Syncytial Virus (RSV) Revenue and Market Share by Type (2011-2021)

4 USA DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) (VOLUME) BY APPLICATION

5 USA DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) MANUFACTURERS ANALYSIS

5.1 Ablynx
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
    5.1.2.1 Ribavirin
    5.1.2.2 Bronchodilator
  5.1.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Ablynx (2015 and 2016)
5.2 ADMA Biologics
  5.2.1 Company Basic Information,Manufacturing Base and Competitors
  5.2.2 Pharmaceuticals Product Type and Technology
    5.2.2.1 Ribavirin
    5.2.2.2 Bronchodilator
  5.2.3 Pharmaceuticals Sales, Revenue, Price of ADMA Biologics (2015 and 2016)
5.3 Agilvax
  5.3.1 Company Basic Information,Manufacturing Base and Competitors
  5.3.2 Agilvax Product Type and Technology
    5.3.2.1 Ribavirin
    5.3.2.2 Bronchodilator
  5.3.3 Agilvax Sales, Revenue, Price of Agilvax (2015 and 2016)
5.4 AlphaVax
  5.4.1 Company Basic Information,Manufacturing Base and Competitors
  5.4.2 AstraZeneca Product Type and Technology
    5.4.2.1 Ribavirin
    5.4.2.2 Bronchodilator
  5.4.3 AlphaVax Sales, Revenue, Price of AlphaVax (2015 and 2016)
5.5 AmVac
  5.5.1 Company Basic Information,Manufacturing Base and Competitors
  5.5.2 AmVac Product Type and Technology
    5.5.2.1 Ribavirin
    5.5.2.2 Bronchodilator
  5.5.3 AmVac Sales, Revenue, Price of AmVac (2015 and 2016)
5.6 Aridis Pharmaceuticals
  5.6.1 Company Basic Information,Manufacturing Base and Competitors
  5.6.2 Aridis Pharmaceuticals Product Type and Technology
    5.6.2.1 Ribavirin
    5.6.2.2 Bronchodilator
  5.6.3 Aridis Pharmaceuticals Sales, Revenue, Price of Aridis Pharmaceuticals (2015 and 2016)
5.7 Artificial Cell Technologies
  5.7.1 Company Basic Information,Manufacturing Base and Competitors
  5.7.2 Artificial Cell Technologies Product Type and Technology
    5.7.2.1 Ribavirin
    5.7.2.2 Bronchodilator
  5.7.3 Artificial Cell Technologies Sales, Revenue, Price of Artificial Cell Technologies (2015 and 2016)
5.8 Astellas Pharma
  5.8.1 Company Basic Information,Manufacturing Base and Competitors
  5.8.2 Astellas Pharma Product Type and Technology
    5.8.2.1 Ribavirin
    5.8.2.2 Bronchodilator
  5.8.3 Astellas Pharma Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
5.9 AstraZeneca
  5.9.1 Company Basic Information,Manufacturing Base and Competitors
  5.9.2 AstraZeneca Product Type and Technology
    5.9.2.1 Ribavirin
    5.9.2.2 Bronchodilator
  5.9.3 AstraZeneca Sales, Revenue, Price of AstraZeneca (2015 and 2016)
5.10 Bavarian Nordic
  5.10.1 Company Basic Information,Manufacturing Base and Competitors
  5.10.2 Bavarian Nordic Product Type and Technology
    5.10.2.1 Ribavirin
    5.10.2.2 Bronchodilator
  5.10.3 Bavarian Nordic Sales, Revenue, Price of Bavarian Nordic (2015 and 2016)
5.11 Biota Pharmaceuticals
5.12 Celltrion
5.13 Codagenix
5.14 Crucell
5.15 CureVac
5.16 Emergent
5.17 Roche
5.18 GenVec
5.19 Gilead Sciences
5.20 GlaxoSmithKline
5.21 Humabs BioMed
5.22 Novavax

6 DRUGS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) TECHNOLOGY AND DEVELOPMENT TREND

6.1 Drugs for Respiratory Syncytial Virus (RSV) Technology Analysis
6.2 Drugs for Respiratory Syncytial Virus (RSV) Technology Development Trend

7 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES

Figure Picture of Drugs for Respiratory Syncytial Virus (RSV)
Table Classification of Drugs for Respiratory Syncytial Virus (RSV)
Figure USA Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type in 2015
Figure Ribavirin Picture
Figure Bronchodilator Picture
Table Applications of Drugs for Respiratory Syncytial Virus (RSV)
Figure USA Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Application in 2015
Figure Infants (Under 6 Month Old) Examples
Figure Babies & Children Examples
Figure Adults Examples
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)
Figure USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
Figure USA Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales of Key Manufacturers (2015 and 2016)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers
Figure 2016 Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers
Table USA Drugs for Respiratory Syncytial Virus (RSV) Revenue by Manufacturers (2015 and 2016)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers
Table 2016 USA Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Type (2011-2021)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Type (2011-2021)
Figure Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type (2011-2021)
Figure USA Drugs for Respiratory Syncytial Virus (RSV) Sales Growth Rate by Type (2011-2021)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Revenue and Market Share by Type (2011-2021)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type (2011-2021)
Figure USA Drugs for Respiratory Syncytial Virus (RSV) Revenue Growth Rate by Type (2011-2021)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Application (2011-2021)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Application (2011-2021)
Figure Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Application (2011-2021)
Figure USA Drugs for Respiratory Syncytial Virus (RSV) Sales Growth Rate by Application (2011-2021)
Table Ablynx Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Ablynx (2015 and 2016)
Table ADMA Biologics Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of ADMA Biologics (2015 and 2016)
Table Agilvax Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Agilvax (2015 and 2016)
Table AlphaVax Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AlphaVax (2015 and 2016)
Table AmVac Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AmVac (2015 and 2016)
Table Aridis Pharmaceuticals Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Aridis Pharmaceuticals (2015 and 2016)
Table Artificial Cell Technologies Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Artificial Cell Technologies (2015 and 2016)
Table Astellas Pharma Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
Table AstraZeneca Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AstraZeneca (2015 and 2016)
Table Bavarian Nordic Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Bavarian Nordic (2015 and 2016)
Table Biota Pharmaceuticals Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Biota Pharmaceuticals (2015 and 2016)
Table Celltrion Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Celltrion (2015 and 2016)
Table Codagenix Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Codagenix (2015 and 2016)
Table Crucell Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Crucell (2015 and 2016)
Table CureVac Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of CureVac (2015 and 2016)
Table Emergent Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Emergent (2015 and 2016)
Table Roche Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Roche (2015 and 2016)
Table GenVec Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of GenVec (2015 and 2016)
Table Gilead Sciences Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Gilead Sciences (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Humabs BioMed Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Humabs BioMed (2015 and 2016)
Table Novavax Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Novavax (2015 and 2016)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories